Survey of Ophthalmology
Volume 46, Issue 1 , Pages 43-55 , July 2001

Complementary and Alternative Medicine for Glaucoma

References 

  1. Gingko biloba for dementia. Medical Letter. 1998;40:63–64
  2. ___: What is complementary and alternative medicine, in: General Information Package—National Center for Complementary and Alternative Medicine Clearinghouse. Silver Spring, MD, NIH Office of Alternative Medicine Clearinghouse, US Public Health Service Publication, Spring 1998
  3. Akiba S, Kawauchi T, Oka T, et al.  Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int. 1998;46:1243–1248
  4. Akisu M, Kultursay N, Coker I, Huseyinov A. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate. 1998;74:439–444
  5. Asregadoo ER. Blood levels of thiamine and ascorbic acid in chronic open-angle glaucoma. Ann Ophthalmol. 1979;11:1095–1100
  6. Astin JA. Why patients use alternative medicine (results of a national study). JAMA. 1998;279:1548–1553
  7. Avunduk AM, Yilmaz B, Sahin N, et al.  The comparison of intraocular pressure reductions after isometric and isokinetic exercises in normal individuals. Ophthalmologica. 1999;213:290–294
  8. Azumi I, Kosaki H, Nakatani H. Effects of metcobolamin (Methycobal) on the visual field of chronic glaucoma—a multicenter open study. Folia Ophthalmol Jpn. 1983;34:873–878
  9. Babizhayev MA, Bunin AY. Lipid peroxidation in open-angle glaucoma. Acta Ophthalmol (Copenh). 1989;67:371–377
  10. Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc. 1987;35:425–430
  11. Baudouin C, Pisella PJ, Ettaiche M. Effects of Egb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefe Arch Clin Exp Ophthalmol. 1996;234:58–63
  12. Birich TV, Birich TA, Marchenko LN: [Lipid peroxidation in the blood of primary glaucoma patients]. Vestn Oftalmol 102:13–5, 1986
  13. Birich TV, Birich TA, Marchenko LN: [Vitamin E in multiple-modality treatment of primary glaucoma patients]. Vestn Oftalmol 102:10–3, 1984
  14. Braquet P. Proofs of involvement of PAF-receptor in various immune disorders using BN 52021 (ginkgolide B) (a powerful PAF-receptor antagonist isolated from Ginkgo biloba). Adv Prost Thromb Leuk Res. 1986;16:179–198
  15. Caprioli J. The ciliary epithelia and aqueous humor. In:  Hart WM editors. Adler's Physiology of the Eye. St. Louis: CV Mosby; 1992;, ed 9
  16. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med. 1984;101:105–112
  17. Chen JX, Chen WZ, Huang HL. Protective effects of Ginkgo biloba extract against lysophosphatidylcholine induced vascular endothelial cell damage. Chung Kuo Yao Li Hsueh Pao. 1988;19:359–363
  18. Chung HS, Harris A, Kristinsson JK, et al.  Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999;15:233–240
  19. Chung KF, Dent G, McCusker M, et al.  Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987;1:248–251
  20. Clark GD, Happel LT, Zorumski CF, Bazan NG. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron. 1992;9:1211–1216
  21. Costagliola C, Iuliano G, Menzione M, et al.  Effect of vitamin E on glutathione content in red blood cells, aqueous humor and lens of humans and other species. Exp Eye Res. 1986;43:905–914
  22. Cupp MJ. Herbal remedies (adverse effects and drug interactions). Am Fam Physician. 1999;59:1239–1245
  23. Dabov S, Goutoranov G, Ivanova R, Petkova N. Clinical application of acupuncture in ophthalmology. Acupunct Electrother Res. 1985;10:79–93
  24. Dauer A, Metzner P, Schimmer O. Proanthocyanidins from the bark of Hamamelis virginiana exhibit antimutagenic properties against nitroaromatic compounds. Planta Med. 1998;64:324–327
  25. De Berardinis E, Tieri O, Polzella A. The chemical composition of the human aqueous humour in normal and pathologic conditions. Exp Eye Res. 1965;4:179–186
  26. De La Paz MA, Epstein DL. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest Ophthalmol Vis Sci. 1996;37:1849–1853
  27. dos Santos MG, Makk S, Berghold A, et al.  Intraocular pressure difference in Goldmann applanation tonometry versus Perkins hand-held applanation tonometry in overweight patients. Ophthalmology. 1998;105:2260–2263
  28. Drance SM, Berry V, Hughes A. Studies in the reproducibility of visual field areas in normal and glaucomatous subjects. Can J Ophthalmol. 1966;1:14–23
  29. Duwiejua M, Zeitlin IJ, Waterman PG, Gray AI. Anti-inflammatory activity of Polygonum bistorta, Guaiacum officinale and Hamamelis virginiana in rats. J Pharm Pharmacol. 1994;46:286–290
  30. Eisenberg DM, Davis RB, Ettner SL, et al.  Trends in alternative medicine use in the United States, 1990–1997 (results of a follow-up national survey). JAMA. 1998;280:1569–1575
  31. Eisenberg DM, Kessler RC, Foster C, et al.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–252
  32. Era P, Parssinen O, Kallinen M, Suominen H. Effect of bicycle ergometer test on intraocular pressure in elderly athletes and controls. Acta Ophthalmol (Copenh). 1993;71:301–307
  33. Erdelmeier CA, Cinatl J, Rabenau J. Anti-viral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med. 1996;62:241–245
  34. Feldman MK. How green are you. Eye Ner. 1999;3:28–33
  35. Fishbein SL, Goodstein S. The pressure lowering effect of ascorbic acid. Ann Ophthalmol. 1972;4:487–491
  36. Flammer J, Drance SM, Zulauf M. Differential light threshold. Short- and long-term fluctuation in patients with glaucoma, normal controls, and patients with suspected glaucoma. Arch Ophthalmol. 1984;102:704–706
  37. Fox RR, Eaton HD, Crary DD. Vitamin A, beta carotene, and hereditary buphthalmus in the rabbit. J Hered. 1982;73:370–374
  38. Gaasterland DE, Pederson JE, MacLellan HM, Reddy VN. Rhesus monkey aqueous humor composition and a primate ocular perfusate. Invest Ophthalmol Vis Sci. 1979;18:1139–1150
  39. Gasser P, Stumpfig D, Schotzau A, et al.  Body mass index in glaucoma. J Glaucoma. 1999;8:8–11
  40. Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116:1433–1437
  41. Grossman M, Swartwout G, Natural eye care . an encyclopedia. Los Angeles: Keats Publishing; 1999;
  42. Haas AL, Boscoboinik D, Mojon DS, et al.  Vitamin E inhibits proliferation of human Tenons capsule fibroblasts in vitro. Ophthalmic Res. 1996;28:171–175
  43. Hayakawa M. Effect of vinpocetine on red blood cell deformability in stroke patients. Arzneimittelforschung. 1992;42:425–427
  44. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol. 1987;105:1544–1549
  45. Helmsen RJ, Gaasterland DE, Rubin M. Induction of buphthalmos in chicks fed an excess of glycine. Invest Ophthalmol. 1973;12:348–353
  46. Hepler RS, Frank IM, Petrus R. Ocular effects of marijuana smoking. In:  Braude MC,  Szara S editor. The Pharmacology of Marihuana. New York, NY: Raven Press; 1976;p. 815–824
  47. Holmin C, Krakau CE. Variability of glaucomatous visual field defects in computerized perimetry. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979;210:235–250
  48. Hufnagel TJ, Schein OD. Suppurative keratitis from herbal ocular preparation. Am J Ophthalmol. 1992;113:722–723
  49. Hughes-Formella BJ, Bohnsack K, Rippke F, et al.  Anti-inflammatory effect of hamamelis lotion in a UVB erythema test. Dermatology. 1998;196:316–322
  50. Jampel HD. Ascorbic acid is cytotoxic to dividing human Tenons capsule fibroblasts. A possible contributing factor in glaucoma filtration surgery success. Arch Ophthalmol. 1990;108:1323–1325
  51. Jampel HD, Moon JI, Quigley HA, et al.  Aqueous humor uric acid and ascorbic acid concentrations and outcome of trabeculectomy. Arch Ophthalmol. 1998;116:281–285
  52. Jayle GE, Aubry M, Gavini H: [Study concerning the action of anthocyanoside extracts of vaccinium myrtillus on night vision]. Ann Ocul 198:556–62, 1965
  53. Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung. 1990;40:589–593
  54. Kaluza G, Strempel I. Effects of self-relaxation methods and visual imagery on IOP in patients with open-angle glaucoma. Ophthalmologica. 1995;209:122–128
  55. Kaluza G, Strempel I, Maurer H. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients. J Behav Med. 1996;19:587–598
  56. Katz J, Sommer A. Risk factors for primary open angle glaucoma. Am J Prev Med. 1988;4:110–114
  57. Kaufman PL, Gablelt BT. Direct, indirect, and dual action parasympathetic drugs. In:  Zimmerman TJ,  Kooner KS,  Sharir M,  Fechtner RD editor. Textbook of Ocular Pharmacology. Philadelphia: Lippincott-Raven; 1997;
  58. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999;4:144–161
  59. Kinsey VE. Transfer of ascorbic acid and related compounds across the blood-aqueous barrier. Am J Ophthalmol. 1947;30:1262–1266
  60. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340:1136–1139
  61. Klein BE, Klein R, Ritter L. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Study. Ophthalmology. 1993;100:1603–1609
  62. Koc RK Akdemir H, Kurtsoy A . Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba, TRH, and methylprednisolone. Res Exp Med (Berl). 1995;195:117–123
  63. Kosaki H, Inoue Y: [A new classification of stages of chronic glaucomas]. Nippon Ganka Gakkai Zasshi 76:1258–67, 1972
  64. Kose K, Dogan P. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants. J Int Med Res. 1995;23:9–18
  65. Koskela PU, Airaksinen PJ, Tuulonen A. The effect of jogging on visual field indices. Acta Ophthalmol (Copenh). 1990;68:91–93
  66. Koskela TK, Reiss GR, Brubaker RF. Is the high concentration of ascorbic acid in the eye an adaptation to intense solar irradiation?. Invest Ophthalmol Vis Sci. 1989;30:2265–2267
  67. Lanthony P, Cosson JP: [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study]. J Fr Ophtalmol 11:671–4, 1988
  68. Le Bars PL, Katz MM, Berman N, et al.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278:1327–1332
  69. Lee P, Lam KW, Lai M. Aqueous humor ascorbate concentration and open-angle glaucoma. Arch Ophthalmol. 1977;95:308–310
  70. Leibowitz HM, Krueger DE, Maunder LR: The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24(Suppl):1980
  71. Lempert P, Cooper KH, Culver JF, Tredici TJ. The effect of exercise on intraocular pressure. Am J Ophthalmol. 1967;63:1673–1676
  72. Li Y, Wolf NS. Effects of age and long-term caloric restriction on the aqueous collecting channel in the mouse eye. J Glaucoma. 1997;6:18–22
  73. Lieb WA, Stark N. Interrelationship of ascorbic acid and facility of outflow (steroid hormones is a possible regulating mechanism of intraocular pressure). In:  Patterson G,  Miller SJH,  Paterson GD editor. Drug Mechanisms in Glaucoma. Edinburgh: Churchill Livingsone; 1966;
  74. Linner E. The pressure lowering effect of ascorbic acid in ocular hypertension. Acta Ophthalmol (Copenh). 1969;47:685–689
  75. Liu SX, Kapingu MC, Wang MS, Chiou GC. Facilitation of retinal function recovery by coumarin derivatives. J Ocul Pharmacol Ther. 1997;13:69–79
  76. Liu SXL, Chiou GCY. Effects of Chinese herbal products on mammalian retinal functions. J Ocul Pharmacol. 1996;12:377–386
  77. Lugasi A, Horvahovich P, Dworschak E. Additional information to the in vitro antioxidant activity of Ginkgo biloba L. Phytother Res. 1999;13:160–162
  78. Marchesilli VL, Bazan NG. Platelet activating factor enhances glutamic acid release in the retina through a presynaptic receptor. Invest Ophthalmol Vis Sci. 1993;34:1048
  79. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun. 1994;201:748–755
  80. Masaki H, Atsumi T, Sakurai H. Protective activity of hamamelitannin on cell damage induced by superoxide anion radicals in murine dermal fibroblasts. Biol Pharm Bull. 1995;18:59–63
  81. Masaki H, Sakaki S, Atsumi T, Sakurai H. Active-oxygen scavenging activity of plant extracts. Biol Pharm Bull. 1995;18:162–166
  82. Matthews MK Jr: Association of ginkgo biloba with intracerebral hemorrhage. Neurology 50:1934, 1998
  83. Mehra KS, Kumar A, Dubey SS, Palodhi GR. The effect of vitamin A and cortisone on ascorbic acid content in the aqueous humor. Ann Ophthalmol. 1982;14:1013–1015
  84. Merritt JC, Crawford WJ, Alexander PC, et al.  Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980;87:222–228
  85. Miyazaki M. The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases. Angiology. 1995;46:53–58
  86. Movaffaghy A, Chamot SR, Petrig BL, Riva CE. Blood flow in the human optic nerve head during isometric exercise. Exp Eye Res. 1998;67:561–568
  87. Nagata M, Kawazu K, Midori Y, et al: [Intracameral and lenticular penetration of locally applied deuterium- labeled vitamin E in rats]. Nippon Ganka Gakkai Zasshi 104:508–10, 2000
  88. Nataloni R. Good nutrition and eye health go hand in hand. Ocular Surgery News. 1999;Oct 15:124–125
  89. Niesel P: [Scattered perimetric study results]. Ophthalmologica 161:180–6, 1970
  90. Nortier JL, Martinez MC, Schmeiser HH, et al.  Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686–1692
  91. Otomo E, Atarashi J, Araki G, et al.  Comparison of vinpocetine with ifenprodil tartrate and dihydroergotoxine mesylate treatment and results of long-term treatment with vinpocetine. Curr Therapeutic Res. 1985;37:811–821
  92. Padgaonkar V, Giblin FJ, Leverenz V. Studies of H2O2-induced effects on cultured bovine trabecular meshwork cells. J Glaucoma. 1994;3:123–131
  93. Passo MS, Goldberg L, Elliot DL, Van Buskirk EM. Exercise training reduces intraocular pressure among subjects suspected of having glaucoma. Arch Ophthalmol. 1991;109:1096–1098
  94. Pate DW, Jarvinen K, Urtti A, et al.  Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr Eye Res. 1995;14:791–797
  95. Pate DW, Jarvinen K, Urtti A, et al.  Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. Pharm Res. 1997;14:1738–1743
  96. Pate DW, Jarvinen K, Urtti A, et al.  Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid- induced ocular hypotension in normotensive rabbits. Life Sci. 1998;63:2181–2188
  97. PDR For Herbal Medicines. Montvale, NJ, Medical Economics, 1999, ed 1
  98. Pissarello C. La curva giornaliera della tensione nell'occhio normale e nel-l'occhio glaucomatoso e influenza di fattori diversi (miotici, iridectomia, irido-sclerectomia, derivativi, pasti) determinata con il tonometro di Schiotz. Ann di Ottal e Cline Ocul. 1915;44:544–636
  99. Ponte F, Giuffre G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol. 1994;85:203–210
  100. Pratt SG. Protect you patients from vitamin toxicity. Review Ophthalmol. 1999;6:104–107
  101. Pritz-Hohmeier S, Chao TI, Krenzlin J, Reichenbach A. Effect of in vivo application of the ginkgo biloba extract EGb 761 (Rokan) on the susceptibility of mammalian retinal cells to proteolytic enzymes. Ophthalmic Res. 1994;26:80–86
  102. Quigley HA, Enger C, Katz J, et al.  Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644–649
  103. Qureshi IA. Does physical fitness influence intraocular pressure?. J Pak Med Assoc. 1997;47:81–84
  104. Qureshi IA. Effects of exercise on intraocular pressure in physically fit subjects. Clin Exp Pharmacol Physiol. 1996;23:648–652
  105. Qureshi IA. The effects of mild, moderate, and severe exercise on intraocular pressure in glaucoma patients. Jpn J Physiol. 1995;45:561–569
  106. Qureshi IA. Effects of mild, moderate and severe exercise on intraocular pressure of sedentary subjects. Ann Hum Biol. 1995;22:545–553
  107. Ralston NS. Successful treatment and management of acute glaucoma using acupuncture. Am J Acup. 1977;5:283–285
  108. Rhee DJ, Spaeth GL, Myers JS: Prevalence of the use of complementary and alternative medicine (CAM) for glaucoma. Ophthalmology (in press)
  109. Rivlin RS. Disorders of vitamin metabolism (deficiencies, metabolic abnormalities, and excesses). In:  Wyngaardn JB,  Smith LH,  Bennett JC editor. Cecil Textbook of Medicine. Philadelphia: WB Saunders; 1992;p. 1170–1183ed 19,
  110. Rivlin RS. Disorders of vitamin metabolism (deficiencies, metabolic abnormalities, and excesses). In:  Wyngaarden JB,  Smith LH,  Bennett JC editor. Cecil Textbook of Medicine. Philadelphia: Saunders; 1992;p. 1170–1183ed 19,
  111. Rosa L, Rosa E, Sarner L, Barrett S. A close look at therapeutic touch. JAMA. 1998;279:1005–1010
  112. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med. 1997;336:1108
  113. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 1996;46:1775–1776
  114. Russell P, Johnson DH. Enzymes protective of oxidative damage present in all decades of life in the trabecular meshwork, as detected by two-dimensional gel electrophoresis protein maps. J Glaucoma. 1996;5:317–324
  115. Saki T, Murata M, Amemiya T. Effect of long-term treatment of glaucoma with vitamin B-12. Glaucoma. 1992;14:167–170
  116. Schappert SM: Office visits for glaucoma: United States, 1991–1992. Advance Data 1995;262:1–13. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control and Prevention, US Public Health Service Publication
  117. Sears ML. Vitamin C as a requirement for the storage of norepinephrine by the iris. Biochem Pharmacol. 1969;18:253–256
  118. Seddon JM, Schwartz B, Flowerdew G. Case-control study of ocular hypertension. Arch Ophthalmol. 1983;101:891–894
  119. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508–518
  120. Shiose Y. The aging effect on intraocular pressure in an apparently normal population. Arch Ophthalmol. 1984;102:883–887
  121. Shiose Y, Kawase Y. A new approach to stratified normal intraocular pressure in a general population. Am J Ophthalmol. 1986;101:714–721
  122. Sold-Darseff J, Leydhecker W: [Acupuncture in glaucoma (authors' transl)]. Klin Monatsbl Augenheilkd 173:760–4, 1978
  123. Song ZH, Slowey CA. Involvement of cannabinoid receptors in the intraocular pressure- lowering effects of WIN55212-2. J Pharmacol Exp Ther. 2000;292:136–139
  124. Soybir G, Koksoy F, Ekiz F, et al.  The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis. Pancreas. 1999;19:143–149
  125. Stewart RH, LeBlanc R, Becker B. Effects of exercise on aqueous dynamics. Am J Ophthalmol. 1970;69:245–248
  126. Stocker FW. New ways of influencing the intraocular pressure. NY State J Med. 1949;49:58–63
  127. Stocker FW, Holt LB, Clower JW. Clinical experiments with new ways of influencing intraocular tension. Arch Ophthalmol. 1948;40:46–55
  128. Szobor A, Klein M. Examinations of the relative fluidity in cerebrovascular disease patients. Ther Hung. 1992;40:8–11
  129. Tashkin DP, Shapiro BJ, Ramanna L, et al.  Chronic effects of heavy marijuana smoking on pulmonary function in healthy young males. In:  Braude MC,  Szara S editor. The Pharmacology of Marihuana. New York, NY: Raven Press; 1976;p. 291–295
  130. Thal LJ, Salmon DP, Lasker B, et al.  The safety and lack of efficacy of vinpocetine in Alzheimers disease. J Am Geriatr Soc. 1989;37:515–520
  131. Trovato A, Monforte MT, Rossitto A, Forestieri AM. In vitro cytotoxic effect of some medicinal plants containing flavonoids. Boll Chim Farm. 1996;135:263–266
  132. Urso G: [Effect of Vaccinium myrtillus anthocyanosides associated with betacarotenes on light sensitivity]. Ann Ottalmol Clin Ocul 93:930–8, 1967
  133. Vale S. Subarachnoid haemorrhage associated with ginkgo biloba. Lancet. 1998;352:36
  134. Vanherweghem JL, Depierreux M, Tielemans C, et al.  Rapidly progressive interstitial renal fibrosis in young women (association with slimming regimen including Chinese herbs). Lancet. 1993;341:387–391
  135. Virno M, Bucci MG, Pecori-Giraldi J, Cantore G. Intravenous glycerol-vitamin C (sodium salt) as osmotic agents to reduce intraocular pressure. Am J Ophthalmol. 1966;62:824–833
  136. Virno M, Bucci MG, Pecori-Giraldi J, Missiroli A: [Findings on the hypotensive intraocular effect of high oral doses of ascorbic acid. Preliminary results in glaucoma therapy]. Boll Ocul 46:259–74, 1967
  137. Walker LP, Brown EH. The alternative pharmacy. Paramus, NJ, Prentice Hall Press, 1999
  138. Weber A. Die Ursache des glaukoms. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1877;23:1–91
  139. Weber A. Uber die wirkung des pilocapium muriaticum. Zbl Med Wiss. 1876;14:49
  140. Weinreb RN, Levin LA. Is neuroprotection a viable therapy for glaucoma?. Arch Ophthalmol. 1999;117:1540–1544
  141. Wendt MD, Soparkar CN, Louie K, et al.  Ascorbate stimulates type I and type III collagen in human Tenons fibroblasts. J Glaucoma. 1997;6:402–407
  142. Wilson MR, Hertzmark E, Walker AM, et al.  A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066–1071
  143. Wingfield BR, Gorman RF. Treatment of severe glaucomatous visual field deficit by chiropractic spinal manipulative therapy (a prospective case study and discussion). J Manipulative Physiol Ther. 2000;23:428–434
  144. Wollensak J, Kewitz H: [One hundred years pilocarpine in ophthalmology (authors' transl)]. Klin Monatsbl Augenheilkd 169:660–3, 1976
  145. Wong S, Ching R. The use of acupuncture in ophthalmology. Am J Chin Med. 1980;8:104–153
  146. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115:1564–1572
  147. Xuan B, Zhou YH, Li N, et al.  Effects of crocin analogs on ocular blood flow and retinal function. J Ocul Pharmacol Ther. 1999;15:143–152
  148. Xuan B, Zhou YH, Varma R, Chiou GC. Effects of some N-nitropyrazole derivatives on ocular blood flow and retinal function recovery after ischemic insult. J Ocul Pharmacol Ther. 1999;15:135–142
  149. Xuan B, Zhou YH, Yang RL, et al.  Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther. 1999;15:207–216
  150. Yamaguchi T, Nagano H, Yamaguchi M, et al.  The effects of kallidinogenase on choroidal blood flow in a hypertensive rabbit model. Curr Eye Res. 1999;18:417–422
  151. Zhu L, Wu J, Liao H, et al.  Antagonistic effects of extract from leaves of ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao. 1997;18:344–347

PII: S0039-6257(01)00233-8

Survey of Ophthalmology
Volume 46, Issue 1 , Pages 43-55 , July 2001

Article Tools